skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease

Review

(2761) Views  (417) Full article downloads

Authors: Sanford R Kimmel

Published Date September 2008 Volume 2008:4(4) Pages 739 - 745
DOI: http://dx.doi.org/10.2147/TCRM.S962

Sanford R Kimmel

University of Toledo College of Medicine, Department of Family Medicine, Toledo, OH, USA

Abstract: Invasive meningococcal disease occurs worldwide causing an estimated 50,000–135,000 deaths each year in addition to significant sequelae. In developed countries the disease is usually sporadic but outbreaks and epidemics, usually due to serogroups B and C, have occurred. In the US, an increasing number of cases are due to serogroup Y. In developing nations, epidemics due to serogroups A and more recently W-135, are common. The tetravalent meningococcal conjugate vaccine to serogroups A, C, Y, and W-135 (MCV4) has been demonstrated to be highly immunogenic and promote immune memory. This article will describe the rationale for the vaccine and its potential role to significantly decrease mortality and morbidity of meningococcal disease in those areas and populations at greatest risk from these serogroups.

Keywords: meningococcal disease, tetravalent meningococcal conjugate vaccine, serogroup








Readers of this article also read:

Bone regeneration: molecular and cellular interactions with calcium phosphate ceramics
Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles
A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study
Biomimetic nanoparticles: preparation, characterization and biomedical applications
Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus
Daily smoking and lower back pain in adult Canadians: the Canadian Community Health Survey
Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model
Selenium nanoparticles inhibit Staphylococcus aureus growth
Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer
Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment